浏览全部资源
扫码关注微信
我国病理学科发展面临的挑战和机遇
Pathology in China: challenges and opportunities
- 第三军医大学学报 2019年41卷第19期 页码：1815-1817
- 作者机构：
400038 重庆，陆军军医大学(第三军医大学)第一附属医院病理科，全军临床病理学研究所
- 作者简介：
[卞修武，博士，主任医师，教授，博士生导师，中国科学院院士，长江学者，国家杰出青年基金获得者。担任中国医师协会病理科医师分会会长，中国抗癌协会肿瘤转移专委会主任委员，国际病理学会(IAP)中国区分会主席，国际肿瘤转移研究学会(MRS)常务理事。主持国家“973”“863”计划，国家重点研发计划，国家自然科学基金创新研究群体、杰出青年基金、重点项目及学科发展战略项目等国家级项目20余项。获国家科技进步一等奖、中华医学会科技奖一等奖和中国抗癌协会科技一等奖各1项，重庆市自然科学一等奖(2项)；获“何梁何利基金科学与技术进步奖”和首届全国创新争先奖。为Int J Clin Exp Pathol和《诊断病理学杂志》主编，《第三军医大学学报》《中华病理学杂志》《临床与实验病理学杂志》副主编，Lab Invest和J Pathol编委。在Nature、Cell Stem Cell、Nature Immunology、Science Translational Medicine等SCI收录杂志发表论文120余篇。主要从事肿瘤干细胞与肿瘤微环境方面的研究。E-mail:bianxiuwu@263.netBIAN Xiuwu, E-mail: bianxiuwu@263.net
- 基金信息：国家自然科学基金委-中国科学院(NSFC-CAS)联合战略研究项目(91859000);国家自然科学基金委-中国科学院(NSFC-CAS)联合战略研究项目(XK2018SMC002)
DOI：10.16016/j.1000-5404.201909212
中图分类号： R36收稿：2019-09-28，
修回：2019-09-29，
纸质出版：2019-10-15
- 稿件说明：
移动端阅览
卞修武, 平轶芳. 我国病理学科发展面临的挑战和机遇[J]. 第三军医大学学报, 2019,41(19):1815-1817.
Xiuwu BIAN, Yifang PING. Pathology in China: challenges and opportunities[J]. Journal of Third Military Medical University, 2019, 41(19): 1815-1817.
卞修武, 平轶芳. 我国病理学科发展面临的挑战和机遇[J]. 第三军医大学学报, 2019,41(19):1815-1817. DOI： 10.16016/j.1000-5404.201909212.
Xiuwu BIAN, Yifang PING. Pathology in China: challenges and opportunities[J]. Journal of Third Military Medical University, 2019, 41(19): 1815-1817. DOI： 10.16016/j.1000-5404.201909212.
摘要
病理学兼具基础医学和临床医学属性，在现代医学发展中发挥了无可取代的作用，在精准医疗中也越来越发挥核心诊断作用。我国病理学科建设和发展历经艰难岁月，创造了辉煌成就，但当前仍存在学科设置不利、人才队伍体量不足、培养途径较少、成长周期较长等诸多问题，并且面临临床需求不断提高、对分子病理结果(包括生物信息)解读能力不足、人工智能的病理应用(智慧病理)创新和转化不力等诸多挑战。同时，我国病理学科也迎来发展机遇。病理学科受到普遍重视，吸引力逐步加大，平台快速改善，多种形式和途径建立的临床病理中心日益壮大，病理学科发展迎来了春天。本述评旨在探讨我国病理学科发展面临的挑战和机遇。
Abstract
As a discipline bridging basic medicine and clinical medicine
pathology not only is irreplaceable in modern medicine
but also plays a 'golden' role for disease diagnosis in the era of precision medicine. The development of pathology in China has experienced hard times but still made remarkable achievements. However
in present
there still exist many problems
such as unclear position of the discipline
shortage of professionals
lack of diverse training approaches
and long period of personnel training
etc. Furthermore
the development of pathology faces many other challenges
such as increasing demands for precise diagnosis from clinicians
insufficient ability to interpret results from molecular pathology (including biological information)
and ineffective translational application of artificial intelligence in pathology (smart pathology). Meanwhile
pathology in China will usher in new historic opportunities for development since the importance of pathology becomes more prominent and attracts more public attention. Moreover
the subject platform for pathology is being improved continuously
and the centers for clinical pathology established through various forms and means have grown stronger and stronger. Therefore
pathology is in the spring season for booming development. This paper aims to discuss the challenges and opportunities faced by pathology in China.
关键词
Keywords
references
[UK Biobank data on 500, 000 people paves way to precision medicine[J ] . Nature, 2018, 562(7726): 163-164. DOI: 10.1038/d41586-018-06950-9 http://dx.doi.org/10.1038/d41586-018-06950-9 .
RHINE C L, NEIL C, GLIDDEN D T, et al . Future directions for high-throughput splicing assays in precision medicine[J ] . Hum Mutat, 2019, 40(9): 1225-1234. DOI: 10.1002/humu.23866.
许燕, 汤烨, 闫雯, 等.病理人工智能的现状和展望[J].中华病理学杂志, 2017, 46(9): 593-595. DOI: 10.3760/cma.j.issn.0529-5807.2017.09.001.
XU Y, TANG Y, YAN W, et al . Current situation and prospect of pathological artificial intelligence[J ] . Chin J Pathol, 2017, 46(9): 593-595. DOI: 10.3760/cma.j.issn.0529-5807.2017.09.001.
CHEN C Y, XING D, TAN L Z, et al . Single-cell whole-genome analyses by linear amplification via transposon insertion (LIANTI)[J ] . Science, 2017, 356(6334): 189-194. DOI: 10.1126/science.aak9787..
COUDRAY N, OCAMPO P S, SAKELLAROPOULOS T, et al . Classification and mutation prediction from non-small cell lung cancer histopathology images using deeplearning[J ] . Nat Med, 2018, 24(10): 1559-1567. DOI: 10.1038/s41591-018-0177-5.
谢丰培, 石宇, 李连宏, 等.中国精准医学发展需要大力加速病理学科建设[J].临床与实验病理学杂志, 2018, 34(1): 4-6. DOI: 10.13315/j.cnki.cjcep.2018.01.002.
XIE F P, SHI Y, LI L H, et al . Development of precision medicine in China needs to speed up the construction of pathology[J ] . Chin J Clin Exp Pathol, 2018, 34(1): 4-6. DOI: 10.13315/j.cnki.cjcep.2018.01.002.
张品南, 冯国飞, 陈艳梅, 等.临床分子病理检查的发展与展望[J].医院管理论坛, 2014, 31(1): 11-13, 10.
ZHANG P N, FENG G F, CHEN Y M, et al . Development and perspective of clinical molecular pathology examination[J ] .Hosp Manag Forum, 2014, 31(1): 11-13, 10.
[《分子遗传学基因检测送检和咨询规范与伦理指导原则2018中国专家共识》制定专家组.分子遗传学基因检测送检和咨询规范与伦理指导原则2018中国专家共识[J ] .中华医学杂志, 2018, 98(28): 2225-2232. DOI: 10.3760/cma.j.issn.0376-2491.2018.28.003 http://dx.doi.org/10.3760/cma.j.issn.0376-2491.2018.28.003 .
[Expert Group for 2018 Chinese Expert Consensus on Criteria and Ethical Guideline for Gene Detection, Inspection and Consultation in Molecular Genetics. Chinese expert consensus on criteria and ethical guideline for gene detection, inspection and consultation in molecular genetics (2018)[J ] . NatlMed J China, 2018, 98 (28): 2225-2232. DOI: 10.3760/cma.j.issn.0376-2491.2018.28.003 http://dx.doi.org/10.3760/cma.j.issn.0376-2491.2018.28.003 .
国家卫生部.医药卫生中长期人才发展规划(2011-2020年)[J].中国继续医学教育, 2011, 3 (2):1-7.
Ministry of Health. Middle- and long-term talents development plan for medicine health system (2011-2020)[J]. Chin Cont Med Edu, 2011, 3(2):1-7.
0
浏览量
0
下载量
0
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
